Mailbox
Boards
Favorites
Whats Hot!
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
MediGene AG (MDGEF) Message Board
Board
Post
Member
Attention will come with this 1st commercial TCR i
Message Board
Public Reply
|
Private Reply
|
Keep
|
Replies
(0)
Post New Msg
Edit Msg
(
) |
Post#
of 1
Posted On: 09/29/2016 4:02:37 AM
Posted By:
dhovekamp42
Attention will come with this 1st commercial TCR immunotherapy deal of German Medigene AG with Bluebird Bio for 4 TCR targets with an upfront of $15m, up to $1b milestones of paid R&D and further gains on future net-sales
bluebirds press release
http://investor.bluebirdbio.com/phoenix.zhtml...ID=2206710
See this short video to understand Medigene AG TCR T-cell approach:
https://vimeo.com/123005836
(1)
(0)
MediGene AG (MDGEF) Stock Research Links
MDGEF Message Board
Company Profile
Time & Sales
Recent News
Filings
Financials
Buy Rating